💥UPSC 2026, 2027, 2028 UAP Mentorship (Jan Batch) + Access XFactor Notes & Microthemes PDF

Health Sector – UHC, National Health Policy, Family Planning, Health Insurance, etc.

Nimesulide Ban 

Why in the News?

The Government of India has banned manufacture, sale and distribution of oral formulations of Nimesulide above 100 mg with immediate effect under Section 26A of the Drugs and Cosmetics Act, 1940.

About Nimesulide

Nimesulide is a Non Steroidal Anti Inflammatory Drug (NSAID) used for acute pain relief and fever reduction.

Key Features of the Drug

  • Pharmacological class: NSAID
    Mechanism of action: Inhibits prostaglandin synthesis by blocking inflammatory chemical mediators
    Therapeutic use: Short term treatment of pain and fever
    Common side effects: Nausea, vomiting, diarrhoea, raised liver enzymes
    Known risk: Hepatotoxicity, especially at higher doses or prolonged use

Reason for the Ban

  • Oral doses above 100 mg pose serious risk to liver health
    • Increased incidence of drug induced liver injury
    Safer alternative analgesics available
    • Action taken under Section 26A, which allows banning drugs harmful to public health
[2019] Which of the following are the reasons for the occurrence of multi-drug resistance in microbial pathogens in India? 

1. Genetic predisposition of some people 

2. Taking incorrect doses of antibiotics to cure diseases 

3. Using antibiotics in livestock farming 

4. Multiple chronic diseases in some people 

Select the correct answer using the code given below. 

(a) 1 and 2 (b) 2 and 3 only (c) 1, 3 and 4 (d) 2, 3 and 4

Get an IAS/IPS ranker as your 1: 1 personal mentor for UPSC 2024

Attend Now

Subscribe
Notify of
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments

JOIN THE COMMUNITY

Join us across Social Media platforms.